Lamin A/C-Related Cardiac Disease: Late Onset With a Variable and Mild Phenotype in a Large Cohort of Patients With the Lamin A/C p.(Arg331Gln) Founder Mutation.

Edgar T Hoorntje, Ilse A Bollen, Daniela Q Barge-Schaapveld, Florence H van Tienen, Gerard J Te Meerman, Joeri A Jansweijer, Anthonie J van Essen, Paul G Volders, Alina A Constantinescu, Peter C van den Akker, Karin Y van Spaendonck-Zwarts, Rogier A Oldenburg, Carlo L Marcelis, Jasper J van der Smagt, Eric A Hennekam, Aryan Vink, Marianne Bootsma, Emmelien Aten, Arthur A Wilde, Arthur van den Wijngaard, Jos L Broers, Jan D Jongbloed, Jolanda van der Velden, Maarten P van den Berg, J Peter van Tintelen
{"title":"<i>Lamin A/C</i>-Related Cardiac Disease: Late Onset With a Variable and Mild Phenotype in a Large Cohort of Patients With the Lamin A/C p.(Arg331Gln) Founder Mutation.","authors":"Edgar T Hoorntje,&nbsp;Ilse A Bollen,&nbsp;Daniela Q Barge-Schaapveld,&nbsp;Florence H van Tienen,&nbsp;Gerard J Te Meerman,&nbsp;Joeri A Jansweijer,&nbsp;Anthonie J van Essen,&nbsp;Paul G Volders,&nbsp;Alina A Constantinescu,&nbsp;Peter C van den Akker,&nbsp;Karin Y van Spaendonck-Zwarts,&nbsp;Rogier A Oldenburg,&nbsp;Carlo L Marcelis,&nbsp;Jasper J van der Smagt,&nbsp;Eric A Hennekam,&nbsp;Aryan Vink,&nbsp;Marianne Bootsma,&nbsp;Emmelien Aten,&nbsp;Arthur A Wilde,&nbsp;Arthur van den Wijngaard,&nbsp;Jos L Broers,&nbsp;Jan D Jongbloed,&nbsp;Jolanda van der Velden,&nbsp;Maarten P van den Berg,&nbsp;J Peter van Tintelen","doi":"10.1161/CIRCGENETICS.116.001631","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Interpretation of missense variants can be especially difficult when the variant is also found in control populations. This is what we encountered for the <i>LMNA</i> c.992G>A (p.(Arg331Gln)) variant. Therefore, to evaluate the effect of this variant, we combined an evaluation of clinical data with functional experiments and morphological studies.</p><p><strong>Methods and results: </strong>Clinical data of 23 probands and 35 family members carrying this variant were retrospectively collected. A time-to-event analysis was performed to compare the course of the disease with carriers of other <i>LMNA</i> mutations. Myocardial biopsies were studied with electron microscopy and by measuring force development of the sarcomeres. Morphology of the nuclear envelope was assessed with immunofluorescence on cultured fibroblasts. The phenotype in probands and family members was characterized by atrioventricular conduction disturbances (61% and 44%, respectively), supraventricular arrhythmias (69% and 52%, respectively), and dilated cardiomyopathy (74% and 14%, respectively). LMNA p.(Arg331Gln) carriers had a significantly better outcome regarding the composite end point (malignant ventricular arrhythmias, end-stage heart failure, or death) compared with carriers of other pathogenic <i>LMNA</i> mutations. A shared haplotype of 1 Mb around <i>LMNA</i> suggested a common founder. The combined logarithm of the odds score was 3.46. Force development in membrane-permeabilized cardiomyocytes was reduced because of decreased myofibril density. Structural nuclear <i>LMNA</i>-associated envelope abnormalities, that is, blebs, were confirmed by electron microscopy and immunofluorescence microscopy.</p><p><strong>Conclusions: </strong>Clinical, morphological, functional, haplotype, and segregation data all indicate that LMNA p.(Arg331Gln) is a pathogenic founder mutation with a phenotype reminiscent of other <i>LMNA</i> mutations but with a more benign course.</p>","PeriodicalId":10277,"journal":{"name":"Circulation: Cardiovascular Genetics","volume":"10 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1161/CIRCGENETICS.116.001631","citationCount":"35","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation: Cardiovascular Genetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1161/CIRCGENETICS.116.001631","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 35

Abstract

Background: Interpretation of missense variants can be especially difficult when the variant is also found in control populations. This is what we encountered for the LMNA c.992G>A (p.(Arg331Gln)) variant. Therefore, to evaluate the effect of this variant, we combined an evaluation of clinical data with functional experiments and morphological studies.

Methods and results: Clinical data of 23 probands and 35 family members carrying this variant were retrospectively collected. A time-to-event analysis was performed to compare the course of the disease with carriers of other LMNA mutations. Myocardial biopsies were studied with electron microscopy and by measuring force development of the sarcomeres. Morphology of the nuclear envelope was assessed with immunofluorescence on cultured fibroblasts. The phenotype in probands and family members was characterized by atrioventricular conduction disturbances (61% and 44%, respectively), supraventricular arrhythmias (69% and 52%, respectively), and dilated cardiomyopathy (74% and 14%, respectively). LMNA p.(Arg331Gln) carriers had a significantly better outcome regarding the composite end point (malignant ventricular arrhythmias, end-stage heart failure, or death) compared with carriers of other pathogenic LMNA mutations. A shared haplotype of 1 Mb around LMNA suggested a common founder. The combined logarithm of the odds score was 3.46. Force development in membrane-permeabilized cardiomyocytes was reduced because of decreased myofibril density. Structural nuclear LMNA-associated envelope abnormalities, that is, blebs, were confirmed by electron microscopy and immunofluorescence microscopy.

Conclusions: Clinical, morphological, functional, haplotype, and segregation data all indicate that LMNA p.(Arg331Gln) is a pathogenic founder mutation with a phenotype reminiscent of other LMNA mutations but with a more benign course.

Lamin A/C相关心脏病:在一大批Lamin A/C p (Arg331Gln)始发突变患者中,具有可变和轻度表型的晚发性
背景:当在对照人群中也发现错义变异时,解释错义变异可能特别困难。这就是我们在LMNA c.992G>A (p.(Arg331Gln))变异中遇到的情况。因此,为了评估这种变异的效果,我们将临床数据评估与功能实验和形态学研究相结合。方法与结果:回顾性收集23例先证者和35例携带该变异的家族成员的临床资料。进行了时间-事件分析,将疾病的病程与其他LMNA突变携带者进行比较。心肌活组织检查用电子显微镜和测量肌节的力发育。用免疫荧光法观察培养成纤维细胞的核膜形态。先证者和家族成员的表型特征为房室传导障碍(分别为61%和44%),室上性心律失常(分别为69%和52%)和扩张性心肌病(分别为74%和14%)。与其他致病性LMNA突变携带者相比,LMNA p.(Arg331Gln)携带者在复合终点(恶性室性心律失常、终末期心力衰竭或死亡)方面的预后明显更好。在LMNA周围共享的1mb单倍型表明有共同的创始人。赔率得分的联合对数为3.46。由于肌原纤维密度降低,膜渗透性心肌细胞的力发育降低。电镜和免疫荧光显微镜证实核lmna相关的结构包膜异常,即水泡。结论:临床、形态学、功能、单倍型和分离数据均表明,LMNA p.(Arg331Gln)是一种致病性始创突变,其表型与其他LMNA突变相似,但病程更为良性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Circulation: Cardiovascular Genetics
Circulation: Cardiovascular Genetics CARDIAC & CARDIOVASCULAR SYSTEMS-GENETICS & HEREDITY
自引率
0.00%
发文量
0
审稿时长
6-12 weeks
期刊介绍: Circulation: Genomic and Precision Medicine considers all types of original research articles, including studies conducted in human subjects, laboratory animals, in vitro, and in silico. Articles may include investigations of: clinical genetics as applied to the diagnosis and management of monogenic or oligogenic cardiovascular disorders; the molecular basis of complex cardiovascular disorders, including genome-wide association studies, exome and genome sequencing-based association studies, coding variant association studies, genetic linkage studies, epigenomics, transcriptomics, proteomics, metabolomics, and metagenomics; integration of electronic health record data or patient-generated data with any of the aforementioned approaches, including phenome-wide association studies, or with environmental or lifestyle factors; pharmacogenomics; regulation of gene expression; gene therapy and therapeutic genomic editing; systems biology approaches to the diagnosis and management of cardiovascular disorders; novel methods to perform any of the aforementioned studies; and novel applications of precision medicine. Above all, we seek studies with relevance to human cardiovascular biology and disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信